Adverse Effects

Not clinically significant.

Contraindications

(1) Head Injury

(2) Hypotension

(3) Administration of acetaminophen or medications containing 

acetaminophen within the previous four hours

(4) Inability to swallow or take medications by mouth

(5) Respiratory distress

(6) Persistent vomiting

(7) Known or suspected liver disease (including patients suspected of current alcohol ingestion)

(8) Allergy to acetaminophen

Dosage

(1) Less than 3 years of age: Not indicated

(2) 3-5 years: Unit dose 160 mg/5 mL

(3) 6-9 years: TWO unit doses of 160 mg/5 mL each for a total 

of 320 mg/10 mL

(4) 10 years and above: FOUR unit doses of 160 mg/5 mL each 

for a total of 640 mg/20 mL

(5) Obtain on-line medical direction for appropriate dosing for patients who are 

significantly underweight or overweight.

Indications

Poisoning by mouth

b) Adverse Effects

May indirectly induce vomiting and cause nausea

) Contraindications

(1) Altered mental status

(2) Patients who have received an emetic

Dosage

(1) Adult: Administer 1 gram/kg

(2) Pediatric: Administer 1 gram/kg 

a) Indications

(1) Signs and symptoms of respiratory distress

(2) Bronchospasm/wheezing associated with:

(a) Asthma

(b) Chronic bronchitis

(c) Emphysema

(d) Allergic reactions (anaphylaxis)

) Adverse Effects

(1) Tachycardia/ Palpitations

(2) Hypertension

(3) Angina

(4) Nervousness/ Anxiety

(5) Tremors

(6) Dizziness

(7) Headache

(8) Sweating

(9) Nausea/ Vomiting

 (10) Sore throat

Contraindications

Inhaler not prescribed for the patient

Dosage

(1) Adult: Patient may receive a maximum of 2 doses (4 puffs) over a 

30-minute period.

(2) Pediatric: Patient may receive a maximum of 2 doses (4 puffs) over a

30-minute period.

(3) Additional doses may be administered with medical consultation.

Indications

Chest pain when acute myocardial infarction is suspected.

Contraindications

Known hypersensitivity

Adverse Effects

(1) Heartburn

(2) Nausea and vomiting

(3) Wheezing

) Dosage

(1) Adult: 324 mg or 325 mg chewed

(2) Pediatric: Not Indicated

Indications

(1) Moderate to severe allergic reaction with respiratory distress or mild 

allergic reaction with history of life-threatening allergic reaction.

(2) Pediatric patients with severe asthma.

Adverse Effects

(1) Tachycardia/ Palpitations

(2) Angina

(3) Headache

(4) Nausea/ vomiting

(5) Dizziness

(6) Hypertension

(7) Nervousness/Anxiety

(8) Tremors

Contraindications

None in the presence of anaphylaxis.

Dosage

(1) Patients 3 years of age or greater:

Adult Auto-injector: 0.3 mg IM

(2) Patients less than 3 years of age:

Pediatric Auto-injector: 0.15 mg IM

) Indications

(1) Patient must have own prescribed sublingual nitroglycerin.

(2) Chest pain 

Adverse Effects

(1) Hypotension

(2) Headache

(3) Dizziness

(4) Tachycardia

Contraindications

(1) Blood pressure below 90 mmHg systolic

(2) Heart rate less than 60

(3) Medication not prescribed for the patient

(4) Pediatric patient under age 12

(5) Any patient having taken medication for Pulmonary Artery Hypertension (eg. Adcirca™ or Revatio™) (NEW ’12) or erectile dysfunction 

(eg. Viagra™, Levitra™, or Cialis™) within the past 48 hours. Medical 

consultation is required to override this contraindication. 

) Dosage

(1) Adult: One tablet or one spray sublingually

(a) Repeat in 3 to 5 minutes if chest pain persists

(b) Maximum of three doses (a combination of patient-administered 

and EMT-administered) of nitroglycerin 

(2) Pediatric: Not Indicated (nitroglycerin contraindicated for children 

under age 12)

(3) Additional doses may be administered with medical consultation

Indications

(1) Altered mental status with known diabetic history

(2) Unconscious for an unknown reason

Adverse Effects

Not clinically significant

Contraindications

Not clinically significant

) Dosage

(1) Adult: Administer 10-15 grams of glucose paste between the gum and 

cheek. Consider single additional dose of glucose paste if not improved after 10 minutes.

(2) Pediatric: Administer 10-15 grams of glucose paste between the gum 

and cheek; this may be accomplished through several small administrations. Consider single additional dose of glucose paste if not improved after 10 minutes

Indications

All medical and trauma patients

Adverse Effects

High concentrations of oxygen will reduce the respiratory drive in 

some COPD patients; these patients should be carefully monitored

Contraindications

None

Dosage

(1) Adult: Administer 12–15 lpm with NRB mask or 2–6 lpm via nasal cannula, unless otherwise directed.

(2) Pediatric: Administer 12–15 lpm via NRB mask or 2–6 lpm via nasal 

cannula, unless otherwise directed.

DEVICE FLOW RATE CONCENTRATION 

Nasal Cannula 2-6 lpm 24-44% 

Venturi Mask Variable 24-50%

Partial Rebreather Mask 6-10 lpm 35-60%

Simple Face Mask 6-10 lpm 35-60%

Pocket Mask 12-15 lpm 50-60%

Non-Rebreather Mask 12-15 lpm 80-100%

Bag-Valve-Mask 12-15 lpm 90-100%